Ivo Aarninkhof
Vorstandsvorsitzender bei Sigmascreening BV
Profil
Ivo Aarninkhof is currently the Chief Executive Officer at Sigmascreening BV and IamFluidics BV.
He has a graduate degree and an MBA from the University of Twente.
Aktive Positionen von Ivo Aarninkhof
Unternehmen | Position | Beginn |
---|---|---|
Sigmascreening BV
Sigmascreening BV Wholesale DistributorsDistribution Services Sigmascreening BV develops new diagnostic products for breast cancer screening. It offers its products to improve the digital mammography in the screening. The company was founded by Kees Grimbergen, Ard den Heeten and Emile Konps in July 2010 and is headquartered in Amsterdam, the Netherlands. | Vorstandsvorsitzender | - |
IamFluidics BV
IamFluidics BV Medical/Nursing ServicesHealth Services IamFluidics BV engages in production of micro particles. It offers IAMF for Industrial applications, which provides an intergratable solution for large scale micro particle production needs. The company was founded by Tom Kamperman, Menno Noorlander and Claas Willem Visse in 2017 and is headquartered in Enschede, the Netherlands. | Vorstandsvorsitzender | - |
Ausbildung von Ivo Aarninkhof
University of Twente | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Sigmascreening BV
Sigmascreening BV Wholesale DistributorsDistribution Services Sigmascreening BV develops new diagnostic products for breast cancer screening. It offers its products to improve the digital mammography in the screening. The company was founded by Kees Grimbergen, Ard den Heeten and Emile Konps in July 2010 and is headquartered in Amsterdam, the Netherlands. | Distribution Services |
IamFluidics BV
IamFluidics BV Medical/Nursing ServicesHealth Services IamFluidics BV engages in production of micro particles. It offers IAMF for Industrial applications, which provides an intergratable solution for large scale micro particle production needs. The company was founded by Tom Kamperman, Menno Noorlander and Claas Willem Visse in 2017 and is headquartered in Enschede, the Netherlands. | Health Services |